UBS Maintains Buy on Equifax, Raises Price Target to $220

Benzinga Newsdesk www.benzinga.com Positive 73.8%

Neg 0% Neu 0% Pos 73.8%

UBS analyst Kevin Mcveigh maintains Equifax (NYSE:EFX) with a Buy and raises the price target from $215 to $220.

Comments

No comments yet. Be the first!